| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |